Shield Therapeutics discuss their Chinese licencing agreement plus John Meyer on Sirius and Arc Minerals
Episode 1693, Jan 08, 2020, 12:48 PM
Shield Therapeutics discuss their exclusive licence agreement in China for the development and commercialisation of Feraccru®/Accrufer®. John Meyer talks about gold plus: Anglo American #AAL, Sirius Minerals #SXX & Arc Minerals #ARCM
On the Vox Markets Podcast Today: 8th January 2020
Carl Sterritt, CEO of Shield Therapeutics #STX discusses their exclusive licence agreement in China for the development and commercialisation of Feraccru®/Accrufer®.
John Meyer, Mining analyst and partner at SP Angel talks about gold plus: Anglo American #AAL, Sirius Minerals #SXX & Arc Minerals #ARCM
(Interview starts at 7 minutes 33 seconds)
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast